Aeglea BioTherapeutics (AGLE) Q4 2022 Earnings

Mar 2Confirmed
May 2022
Aug 2022
Nov 2022
Q4 2022
-0.37
-0.31
-0.24
-0.18

Details

Expected EPS
-0.2
Actual EPS
-0.18
Surprise EPS
0.02
Surprise Percent
+10%

Description

⁨Aeglea BioTherapeutics⁩ (⁦AGLE⁩) has reported earnings of ⁦-0.18⁩ per share for ⁦Q4 2022⁩.

0 Comments

Share your thoughts